Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel… and to placebo? Epilepsy & behavior : E&B Kanner, A. M., Patten, A., Ettinger, A. B., Helmstaedter, C., Meador, K. J., Malhotra, M. 2021; 125: 108380


The purpose of this study was to establish whether a past psychiatric history could play a role in the development of psychiatric treatment-emergent adverse events (PTEAEs) in patients randomized to perampanel (PER) or placebo.The development of PTEAEs was compared between patients with/without a psychiatric history in a post hoc analysis from four randomized placebo-controlled trials (RPCTs) of PER (304/305/306/335) in patients with treatment-resistant focal epilepsy.Among the 2,187 patients enrolled in the RPCTs, 352 (16.1%) had a psychiatric history (PER n?=?244; placebo n?=?108), while 1835 patients (83.9%) did not (PER n?=?1325; placebo n?=?510). Compared to patients without a psychiatric history, those with a positive history reported more PTEAEs for both patients randomized to PER (11.8% vs. 29.9%, p?

View details for DOI 10.1016/j.yebeh.2021.108380

View details for PubMedID 34735963